Adhesives & Sealants News
Evonik opens new production facility for silane-modified polymers in Essen
Development of a new, flexible technology platform for silane-modified polymers
Eco-friendly products for a wide range of applications
Evonik Industries plans to produce a new class of silane-modified polymers at its Essen site in the 2nd quarter 2013. The new product line will be sold under the brand name TEGOPAC®.
TEGOPAC® stands for a new and flexible technology platform for silane-modified polymers. Among other applications, these eco-friendly products serve as binders for a number of adhesives and sealants.
"With this innovative technology developed by Evonik, polymer structures can be individually configured in accordance with application requirements," explains Dr. Sabine Giessler-Blank, the head of Innovation Management of the Interface & Performance Business Line in Essen.
Formulators of high-quality sealants and adhesives appreciate the TEGOPAC® Product Line for its high variability with regard to tensile strength, elasticity and the adjustment of the adhesion forces. Thanks to the option to manufacture formulations that are free of isocyanates and methanol, the new technology is also an eco-friendly alternative to conventional products.
The combination with the existing Polymer ST product portfolio of Evonik Hanse GmbH, which was acquired in 2011 (former Hanse Chemie Group), offers customers a broad property spectrum for applications in construction, transport, and assembly. The new technology also offers the opportunity to open up completely new application areas.
The Consumer Specialties Business Unit of Evonik has many years of experience with the use of additives for the construction, adhesives, and plastics industry. Thanks to its specialized know-how and continuous technology improvements, Evonik is a valuable and reliable partner for a number of industries.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.6 billion and an operating profit (adjusted EBITDA) of about €2.6 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.